Vincent Munster, Ph.D.

Vincent Munster, Ph.D.

Chief, Virus Ecology Section

Major Areas of Research

  • Natural reservoirs of emerging viruses and elucidation of the underlying biotic and abiotic drivers of zoonotic and cross-species transmission events
  • Evolutionary dynamics of emerging viruses in the context of virus-host ecology
  • Modeling zoonotic and cross-species transmission of emerging viruses and the efficacy of outbreak intervention strategies

Program Description

Emerging viral diseases are a major challenge to the safety of the world in the 21st century. The emergence of Ebola virus, avian influenza H5N1, Nipah and Hendra viruses, severe acute respiratory syndrome coronavirus (SARS-CoV) and, more recently, the novel Middle East respiratory syndrome (MERS) CoV, and avian influenza H7N9 has revealed the need for a more comprehensive understanding of the drivers of infectious disease outbreaks.

Birds, mammals, and arthropods are the principal source of most emerging viruses in the human population. Very little is known about the interaction of the viruses and their respective natural hosts and the changes in virus-host ecology resulting in cross-species transmission events, such as outbreaks in humans.

The main objectives of our research program aim to identify the underlying biotic or abiotic changes in virus-host ecology that allow these emerging viral pathogens to cross the species barrier. Recognizing both the strengths and weaknesses of a unilateral focus on field research on one hand and experimental research on the other, we set out to combine the best of both approaches in one research program, where we aim to identify drivers of cross-species transmission from data gathered in the field and model these drivers under experimental conditions in the lab.





Adult female hammer-headed bat

An adult female hammer-headed bat with attached young hangs on release line in Republic of Congo.

Credit
Dr. Vincent Munster

An adult female hammer-headed bat with attached young hangs on release line in Republic of Congo.

Credit:
Dr. Vincent Munster

To identify natural reservoirs of emerging viruses and to enhance our understanding of the underlying biotic and abiotic drivers of zoonotic and cross-species transmission events

The incorporation of host ecology in pathogen surveillance networks enables us to study the complex relationships between virus and host ecology. Currently, field study sites have been initiated in the Republic of the Congo, where we initiated long-term studies on the role of fruit bats in the ecology of Ebola virus. To monitor the seasonal, weekly, and daily migration patterns of natural reservoirs such as fruit bats, we will use satellite telemetry. Linking seasonal biological phenomena (appearance of fruit bats in the area, fruiting and flowering events of food sources, and dates of outbreaks) with virus prevalence data will likely result in the identification of driving biological forces behind temporal and spatial patterns of virus prevalence. Research in the Republic of the Congo is performed with our collaborators of the Wildlife Conservation Society and the Laboratoire National de Santé Publique in Brazzaville and focuses both on the public health and the conservation aspects of infectious diseases.





Hammer-headed bat

Virus Ecology Unit postdoctoral fellow, Dr. Steph Seifert, releases a hammer-headed bat fitted with a GPS tracker in Republic of Congo.

Credit
©Sarah Olson/WCS

Virus Ecology Unit postdoctoral fellow, Dr. Steph Seifert, releases a hammer-headed bat fitted with a GPS tracker in Republic of Congo.

Credit:
©Sarah Olson/WCS

See the field study location in Google maps.
Visit the Wildlife Conservation Society.

Experimental modeling of zoonotic and cross-species transmission of emerging viruses and the efficacy of outbreak intervention strategies

For a wide variety of novel emerging infectious viruses (e.g., Nipah virus, Ebola virus, MERS-CoV), no prophylactic or therapeutic intervention measures are currently available to prevent or contain outbreak events. In addition, very limited information is available on the route of zoonotic and human-to-human transmission for most of these viruses. Currently, our best hope to prevent or intervene in future outbreaks of these viruses lies in the potential to efficiently block transmission and thereby spread of the outbreak. In order to efficiently establish prevention strategies, detailed knowledge on mechanisms of pathogenicity and transmission (contact transmission, fomite transmission, aerosol transmission, or foodborne or vertical transmission) in the context of abiotic (temperature, humidity, airflow) and biotic (routes of transmission, immune status, receptor distribution, amount of shed virus) factors is needed. The newly developed transmission models will be used to evaluate the efficacy of current outbreak intervention strategies, such as vaccination and antiviral therapies. A more comprehensive understanding of transmission events is likely to make an important contribution to the control of emerging zoonotic infections.

Training, capacity building, and knowledge transfer

The field program of the Virus Ecology Unit operates from the International Centers for Excellence in Research (ICER) at the Laboratoire National de Santé Publique, Brazzaville, Republic of the Congo. The goal of the ICER program in the Republic of the Congo is to facilitate the expansion of local research capacity by training young scientists and improving laboratory and clinical infrastructure. The Virus Ecology Unit has been actively involved in training local scientists in molecular diagnostics for a variety of diseases (e.g., Ebola virus, chikungunya virus, dengue virus, and yellow fever virus) and has developed collaborative research programs with local researchers.





Adult male hammer-headed bat

An adult male hammer-headed bat with GPS tracking collar awaits release in Republic of Congo.

Credit
©Sarah Olson/WCS

An adult male hammer-headed bat with GPS tracking collar awaits release in Republic of Congo.

Credit:
©Sarah Olson/WCS

Biography

Dr. Vincent Munster received his Ph.D. in virology from Erasmus University, Rotterdam, the Netherlands, in 2006. During his Ph.D. studies, Dr. Munster studied the ecology, evolution, and pathogenesis of avian influenza viruses. He continued his training at the Erasmus Medical Center from 2006 to 2009, where he worked within the Center for Research on Influenza Pathogenesis and Surveillance (CRIPS) focusing on pathogenicity and human-to-human transmission of influenza A viruses. Dr. Munster joined NIAID’s Laboratory of Virology as a visiting fellow in 2009 to study the ecology of filoviruses and henipaviruses. In 2013, Dr. Munster established the Virus Ecology Unit as an independent tenure-track investigator. The mission of the Virus Ecology Unit is to elucidate the ecology of emerging viruses and drivers of zoonotic and cross-species transmission. The Virus Ecology Unit uses a combined field and experimental research approach and conducts research at the state-of-the-art high- and maximum-containment facilities of the Rocky Mountain Laboratories, as well as at field study sites in Africa (the Republic of the Congo, Mali), the Caribbean (Trinidad and Tobago), and the Middle East (Jordan). Dr. Munster was awarded the European Scientific Working Group on Influenza (ESWI) Best Body of Work Award for Young Scientists in 2011, the MERCK-IAAC young investigator award in 2014, and the European Society for Virology Young Investigator Award in 2016.

Research Group

Munster Research Group Image

Left to right: Taylor Saturday, Claude Kwe Yinda, Bob Fischer, Vincent Munster, Jyothi Purushotham, Myndi Holbrook, Julia Port, Zack Weishampel, Jade Riopelle, Neeltje van Doremalen, Jonathan Schulz.

Credit
NIAID

Left to right: Taylor Saturday, Claude Kwe Yinda, Bob Fischer, Vincent Munster, Jyothi Purushotham, Myndi Holbrook, Julia Port, Zack Weishampel, Jade Riopelle, Neeltje van Doremalen, Jonathan Schulz.

Credit: NIAID

Current Lab Members

  • Zack Weishampel, B.Sc. (Postbaccalaureate IRTA)
  • Jade Riopelle, B.Sc. (Postbaccalaureate IRTA) 
  • Taylor Saturday, B.Sc. (Postbaccalaureate IRTA)
  • Kwe Claude Yinda, Ph.D. (Visiting Fellow)
  • Julia Port, Ph.D. (Visiting Fellow)
  • Shane Gallogly, B.A., (contractor)
  • Jonathan E. Schulz, B.Sc. (Contractor)
  • Bob Fischer, Ph.D. (Contractor)
  • Neeltje van Doremalen, Ph.D. (Associate Staff Scientist)
  • Vincent Munster, Ph.D. (Principal Investigator)

Former Lab Members

  • Danielle Adney, Ph.D. DVM, Lovelace Biomedical
  • Vicky Avanzato, Ph.D. medical student, Emory University
  • Trenton Bushmaker, B.Sc. RML NIAID
  • Irene Owusu Donkor, MPH Ph.D. (APTI fellow), University of Ghana
  • Dania Figueroa, B.Sc. graduate student Mount Sinai Icahn School of Medicine
  • Myndi Holbrook, B.Sc. RML, NIAID
  • Seth Judson, B.Sc. MD Infectious Disease fellow Johns Hopkins University
  • Michael Letko, Ph.D. Assistant Professor, Washington State University
  • Jun Li, Ph.D., Hangzhou CDC, Hangzhou, China
  • Jeremiah Matson, Ph.D. medical student Marshall University
  • Rebekah McMinn, B.Sc. graduate student, Colorado State University
  • Kerri Miazgowicz, Ph.D. Oregon state University
  • Megan Miller, Ph.D. Colorado State University
  • Shauna Milne-Price, MD. resident Family Medicine
  • Jyothi Purushotham, Ph.D. postdoc, The Scripps Research Institute
  • Joe Prescott, Ph.D. junior PI, Robert Koch Institute, Berlin, Germany
  • Stephanie Seifert, Ph.D. Assistant Professor, Washington State University
  • John Thomson, M.Phil. medical student, University of Michigan

Selected Publications

van Doremalen N, Lambe T, Spencer A, Belij-Rammerstorfer S, Purushotham JN, Port JR, Avanzato VA, Bushmaker T, Flaxman A, Ulaszewska M, Feldmann F, Allen ER, Sharpe H, Schulz J, Holbrook M, Okumura A, Meade-White K, Perez-Perez L, Edwards NJ, Wright D, Bissett C, Gilbride C, Williamson BN, Rosenke R, Long D, Ishwarbhai A, Kailath R, Rose L, Morris S, Powers C, Lovaglio J, Hanley PW, Scott D, Saturday G, de Wit E, Gilbert SC, Munster VJ. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature. 2020;586(7830):578-82.

Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020.

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020.

Port JR, Yinda CK, Avanzato VA, Schulz JE, Holbrook MG, van Doremalen N, Shaia C, Fischer RJ, Munster VJ. Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo. Nat Microbiol. 2022;7(2):213-23.

Kuisma E, Olson SH, Cameron KN, Reed PE, Karesh WB, Ondzie AI, Akongo MJ, Kaba SD, Fischer RJ, Seifert SN, Munoz-Fontela C, Becker-Ziaja B, Escudero-Perez B, Goma-Nkoua C, Munster VJ, Mombouli JV. Long-term wildlife mortality surveillance in northern Congo: a model for the detection of Ebola virus disease epizootics. Philos Trans R Soc Lond B Biol Sci. 2019;374(1786):20190658.

Visit PubMed for a complete publication list

Content last reviewed on